Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2)

W. Chen (Oxford, United Kingdom), R. Borst (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), M. Chizari (Oxford, United Kingdom), L. Chocarro De Erauso (Oxford, United Kingdom), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge MA, United States of America), D. Sandham (Cambridge MA, United States of America), L. Xue (Oxford, United Kingdom)

Source: International Congress 2019 – Novel targets and mechanisms in asthma
Session: Novel targets and mechanisms in asthma
Session type: Oral Presentation
Number: 4953

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Chen (Oxford, United Kingdom), R. Borst (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), M. Chizari (Oxford, United Kingdom), L. Chocarro De Erauso (Oxford, United Kingdom), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge MA, United States of America), D. Sandham (Cambridge MA, United States of America), L. Xue (Oxford, United Kingdom). Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2). 4953

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: